Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness in Chronic Kidney Disease
Publication Highlight: Activation of the IKK2/NF-κB pathway in VSMCs inhibits calcified vascular stiffness
APS 2024: American Physiological Society
Explore the science behind the biggest issues impacting life and health today and make connections that will last a lifetime at the 2024 American Physiology Summit (#APS2024). Held annually by the American Physiological Society (APS 2024), the Summit convenes 3,000 researchers, educators and students from around the world who are teaching, learning and working in the physiological sciences. Scintica will be there at booth 139. We are also hosting a workshop on Saturday, April 6 at 10:15am – 11am. Make sure to stop by to see how our preclinical solutions can support your research!
When does the Meeting Take Place?
Tuesday, April 4 – Sunday, April 7
Where is this year’s APS 2024 Annual Meeting?
Long Beach Convention Center
Long Beach, CA
Read more about Science!
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology
Application Note: Bioprinting 3D Multi-cellular Cartilage Spheroids Using Laser-Assisted Technology View Paper Here
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways
Publication Highlight: Single High-Dose Erythropoietin Disrupts Bone Homeostasis via Osteoclastogenic Pathways View Paper
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in BCMA CAR-NK Therapy
Publication Highlight: Long-Term Optical Imaging Reveals Bone Marrow Clearance and Extramedullary Escape in
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB and its downstream factors
Publication Highlight: Overexpression of IL-32γ inhibits skin cancer formation through suppression of NF-κB
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders
Publication Highlight: The role of phosphodiesterase 5 inhibitors in attenuating obesity-induced metabolic disorders